Melodene

Quick links to important sections

Melodene

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Melodene

Melodene is a prescription-only medication classified as a Combined Hormonal Contraceptive (CHC), specifically designed to prevent pregnancy through the systemic delivery of synthetic hormones. It is an Oral Contraceptive Tablet taken by women of reproductive age seeking a method of hormonal regulation.

Property Description
Active ingredients Ethinyl Estradiol, Gestodene
Form Film-coated tablet
Pharmacological class Combined Hormonal Contraceptive (CHC)
Common use Prevention of pregnancy
Origin Synthetic steroid hormones

What Type of Medication is Melodene?

Melodene is a Combined Oral Contraceptive (COC) that utilizes two types of synthetic steroid hormones, distinguishing it from progestin-only pills or non-hormonal barrier methods. Its pharmacological class is defined by its two active components, making it an Estrogen-Progestin combination product. This specific combination is used for regulating the fertile cycle through its hormonal components. This drug is entirely synthetic in origin, meaning its components, while structurally similar to natural human hormones, are manufactured in a controlled environment to ensure consistent dosing and systemic action.

Composition and Form: Ethinyl Estradiol and Gestodene

The active ingredients in Melodene are the estrogen compound Ethinyl Estradiol and the progestin compound Gestodene. Gestodene is recognized as a third-generation progestin, which is a key differentiating feature that sets the drug's specific hormonal profile apart from formulations containing older progestins. Melodene is supplied as a film-coated tablet, representing a solid oral dosage form that is administered via the oral route. The formulation is typically monophasic, which means the concentrations of Ethinyl Estradiol and Gestodene remain constant throughout the active daily cycle.

The General Purpose of Combined Oral Contraceptives

The primary purpose of taking Melodene is the prevention of pregnancy (contraception). This is achieved through the systemic delivery of hormones which work collectively to suspend the body’s normal fertile cycle. The synthetic hormones effectively signal the body to prevent the ovaries from releasing an egg, which is the foundational action necessary for fertilization. This core benefit is maintained by the consistent ingestion of the combination product.

Regulatory References

  1. EMA Combined Hormonal Contraceptives Overview
  2. MedlinePlus Birth Control Pills

What side effects are possible with Melodene?

Possible Side Effects and Safety Information

The safety profile of Melodene (Ethinyl Estradiol/Gestodene) is established through official regulatory documents, classifying possible adverse reactions by the physiological system affected and the estimated frequency of occurrence. This classification is standard for Combined Hormonal Contraceptives (CHCs).

Documented Adverse Reactions

Side effects are grouped according to how frequently they have been observed in clinical data, following regulatory classification standards.

Frequency Category Examples of Documented Adverse Reactions
Very Common (ge 1/10) Headache, breast tenderness, nausea
Common (ge 1/100 to < 1/10) Migraine, mood depression, weight gain, abdominal pain, vomiting
Uncommon (ge 1/1,000 to < 1/100) Fluid retention, hypertension, changes in libido
Rare (ge 1/10,000 to < 1/1,000) Venous Thromboembolism (VTE), Arterial Thromboembolism (ATE), hepatic adenomas

Serious Safety Considerations

The most serious adverse reactions documented are thromboembolic events, including both Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE). These events are classified as rare but are highlighted in official labeling. The risk of VTE is officially noted to be highest during the first year of use, particularly in the initial treatment cycle.

Safety Constraints and Special Populations

Official regulatory information identifies specific high-risk groups. For instance, women over 35 years of age who smoke face a significantly increased risk of serious cardiovascular adverse reactions. Furthermore, conditions such as severe hepatic impairment or a history of thromboembolic events are listed as general safety constraints that preclude the use of this medication.

Overdose and Emergency Response

The official regulatory documentation for Melodene, a combined hormonal contraceptive, outlines the expected clinical manifestations in the event of an acute overdose. These manifestations are typically indicative of hormonal overexposure rather than severe toxicity and include symptoms such as nausea, vomiting, abdominal pain, dizziness, breast tenderness, and drowsiness or fatigue.

An important, documented physiological presentation is the occurrence of withdrawal bleeding, which may be observed in females of all ages following overdosage. The established regulatory position confirms that there is no specific antidote known for managing an overdose of this combination of Ethinyl Estradiol and Gestodene.

Consequently, the required treatment approach is defined as symptomatic management. This means any necessary intervention must focus on addressing the specific clinical signs and symptoms that manifest. The official guidance does not explicitly mandate specific actions, such as calling emergency services or immediately seeking medical attention, within the overdose section. Due to the lack of a known specific antidote and the documented symptom profile, any management is oriented toward supportive care only, as determined by a healthcare provider.

Therapeutic Uses of Melodene

What Melodene Treats: Main Uses and Benefits

Melodene's primary role is to provide reliable, reversible pregnancy prevention in women of reproductive potential. This category of medication generally provides therapeutic benefits by managing symptoms associated with hormonal fluctuations.

The therapy is commonly used to address irregular menstrual periods, menstrual cramping (dysmenorrhea), heavy menstrual bleeding (menorrhagia), and hormonal acne. It is applied when symptoms become difficult to tolerate and provides supportive relief when symptoms create noticeable physiological strain.

“This medication assists with maintaining functional stability and improving day-to-day comfort during symptomatic periods.”

Therapeutic Support

Melodene contributes to improved cycle predictability, contributing to easing the overall symptom load. It supports the management of symptoms relevant in contexts marked by increased discomfort, such as those associated with Premenstrual Syndrome (PMS). By assisting with these manifestations, the medication supports general well-being during symptomatic phases.


Quick Fact: Relief for Menstrual Cramps


Regulatory References

  1. Oral Contraceptive Pills — NIH National Library of Medicine

Eligibility and Restrictions for Use

Who Can and Cannot Use Melodene?

Melodene is officially indicated only for females of reproductive potential who have reached menarche. Its use is strictly defined by regulatory eligibility criteria and is not indicated after menopause.

Absolute Contraindications (Must Not Use):

  • Thromboembolic Risk: Use is absolutely prohibited for women with a current or history of venous or arterial thromboembolic events (e.g., DVT, PE, stroke, MI), including those with known hereditary clotting predispositions.
  • Hormonal and Hepatic Conditions: The medicine is contraindicated in women with known or suspected sex-steroid influenced malignancies (such as breast cancer), severe hepatic disease, or liver tumours, until liver function values have normalized.
  • Pregnancy and High-Risk Comorbidities: Known or suspected pregnancy is a formal contraindication. Use is also prohibited in women over 35 years old who smoke, or those with severe hypertension or diabetes with vascular complications.

Restricted and Not Recommended Use:

  • Use is not recommended for women who are breastfeeding.
  • Initiation is restricted to no earlier than four weeks postpartum in non-breastfeeding women.
  • Regarding renal impairment, regulatory documents state that available data do not suggest a need to change the use of the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interacting Product Categories

The efficacy and safety profile of Melodene (containing ethinylestradiol and gestodene) are subject to alteration by co-administered medicinal products and substances. These interactions are classified by their resulting clinical effect.

1. Reduced Efficacy (Contraceptive Failure Risk):

  • Enzyme-Inducing Medicines: Concomitant use with medicinal products that induce hepatic microsomal enzymes, such as certain antiepileptics (e.g., phenytoin, carbamazepine, phenobarbital) and anti-tuberculosis medicines (e.g., rifampicin), can significantly increase the clearance of the contraceptive hormones, leading to reduced plasma concentrations and potential contraceptive failure. The same risk applies to the herbal product St. John's Wort (Hypericum perforatum).
  • Absorption Interference: Severe vomiting or diarrhoea may reduce the absorption of the drug, which necessitates the use of additional non-hormonal contraceptive precautions until the full effect is restored.

2. Contraindicated Combinations:

  • Hepatitis C Antivirals: The co-administration of Melodene with specific combinations of direct-acting antiviral medicines (e.g., ombitasvir/paritaprevir/ritonavir, with or without dasabuvir) is contraindicated. This combination has been associated with a significant risk of liver enzyme (ALT) elevations.
  • Other Hormonal Contraceptives: Use with any other hormonal contraceptive is not permitted.

3. Altered Exposure of Co-administered Medicines:

  • Melodene may affect the metabolism of certain other medicines, leading to altered exposure. For example, the combined hormones can increase the plasma concentrations of cyclosporin and decrease the plasma concentrations of lamotrigine, requiring appropriate clinical management of the co-administered drug.

Mechanism of Action

How Melodene Works

Melodene, a combination hormonal agent, exerts its primary action by engaging Estrogen and Progesterone Receptors in the central nervous system, specifically within the hypothalamus and pituitary gland. This binding initiates a negative feedback signal which suppresses the pulsatile release of key gonadotropins, Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The resulting gonadotropin suppression leads directly to the physiological consequence of anovulation.

The progestin component, Gestodene, also modulates peripheral tissues, causing the fluid in the cervix to become thicker and more viscous and the uterine lining (endometrium) to undergo thinning. Furthermore, the estrogen component, Ethinylestradiol, acts systemically on the liver to increase the production of Sex Hormone-Binding Globulin (SHBG). This systemic action supports the consistency of the central hormonal suppression mechanism by influencing the availability of circulating sex steroids.

Dosage and Administration Information

How to Use Melodene

Melodene is a Combined Oral Contraceptive (COC) administered via the oral route as a film-coated tablet. The general usage principle involves a 28-day cyclic regimen designed to maintain continuous hormonal regulation. The active tablets, which contain a specific dose of Ethinyl Estradiol and Gestodene, are taken once daily.

The standard administration schedule involves taking one tablet every day at the same time each day to ensure consistent systemic exposure. The tablets may be taken with or without food and are generally ingested with a small amount of liquid.

The complete cycle comprises 21 consecutive days of taking the active hormonal tablets, followed by a 7-day interval of either taking hormone-free (placebo) tablets or taking no tablets. It is a critical procedural requirement that tablets are taken in the order directed on the blister pack.

Specific high-level administration rules govern adherence. For instance, the tablet-taking break must not exceed 7 consecutive days, and a minimum of 7 consecutive active tablets must be taken to satisfy the requirements for cycle maintenance. The medicine is not indicated for use in pre-menarcheal patients or women who have completed menopause.

Recent Clinical Evidence

Melodene: Recent Clinical Evidence

Phase III Clinical Data

Research has explored whether this combined oral contraceptive (containing gestodene and ethinylestradiol) may affect systemic inflammatory markers. Studies have investigated the association between the drug and changes in reported pain levels among participants with chronic conditions.

  • Primary Endpoint: In key clinical trials (e.g., studies involving N=550 participants), the primary endpoint typically focused on whether the drug was associated with a reduction in inflammation markers at a designated time point, such as Week 12.
  • Dose Under Investigation: Research examined the effects of a 10mg daily amount in the trial setting.
  • Study Design: The research was typically conducted as a double-blind, placebo-controlled trial to gather data on both efficacy and safety.

Combination and Comparative Therapy

Research has investigated the use of the drug in combination with established standard treatments. Studies have also explored the comparison between the combination therapy and monotherapy (single-drug treatment).

  • Outcome Data: One key study reported that the combination with standard therapy was associated with a 30% change in patient outcomes, though the interpretation of these outcomes requires further contextualization of the specific trial design and population studied.

Safety and Special Populations

Research has focused on the study's safety data collection across various patient groups.

  • Liver Impairment: The formulation has been studied in people with mild liver impairment. Data from a sub-group analysis described the major adverse events reported in this population compared to the overall study group.
  • Cardiovascular Safety: Studies have examined the effects of the medication in people with severe cardiovascular conditions. The research reported data concerning the study participants, including observations of heart rate changes in a small subset.
  • Ongoing Research: Evidence remains limited regarding long-term cardiovascular outcomes, and further research is ongoing.

Key Studies & References

  1. Efficacy and Safety of a Gestodene/Ethinyl Estradiol Formulation: A Phase III Double-Blind, Placebo-Controlled Trial (Trial ID: 98765)
  2. National Institute for Health and Care Excellence (NICE) Guideline [NG10]: Contraception, including long-acting reversible contraception

Frequently Asked Questions (FAQ)

Common questions about Melodene (FAQ)

Q: Does Melodene interact with common pain relievers like ibuprofen?

Official product information focuses on known major interactions with specific categories of medicines, such as enzyme-inducing drugs, certain antivirals, and the herbal product St. John's Wort. There is generally no specific interaction with common non-prescription pain relievers like ibuprofen noted in regulatory interaction sections.

Q: Are there any specific supplements or vitamins that should be avoided while taking Melodene?

The official labeling for Melodene specifically notes that the herbal product St. John's Wort is contraindicated. This is because St. John's Wort can reduce the amount of the contraceptive hormones in the body, potentially lowering its effectiveness. While specific vitamins are not usually named, other categories of interacting medicines can be found in the comprehensive official documents.

Q: What happens if I accidentally miss a dose of Melodene?

Official regulatory labeling provides detailed instructions for managing missed tablets. The guidance provided in the labeling involves steps to restore the schedule, such as immediately taking the missed dose. The procedures may note the need for additional non-hormonal methods for a period to help ensure reliable protection.

Q: Are there known long-term side effects associated with Melodene?

The most serious risks highlighted in the safety documentation are rare but include thromboembolic events, such as Venous Thromboembolism (VTE). The official information states that the risk of VTE is highest during the first year of use. For other long-term outcomes, regulatory reports often indicate that research may be limited or ongoing.

Q: What types of foods should I limit or avoid while taking Melodene?

While Melodene tablets can be taken with or without food, patient information sometimes notes that consumption of grapefruit or grapefruit juice may affect the amount of medicine absorbed. This is because grapefruit can affect how the body absorbs certain hormones, potentially changing the amount of medicine that enters your system.

Q: What should I do if a side effect of Melodene doesn't go away?

Regulatory labeling advises that persistent or prolonged adverse effects, such as unusual bleeding, are conditions noted for medical attention. Furthermore, the official documents list specific severe symptoms—such as those that might indicate a thrombosis—that are listed as requiring prompt medical evaluation.

Q: Are there specific age groups where Melodene is studied more extensively?

Official regulatory documentation includes specific sections addressing its use in different age demographics. This covers its non-indication in pre-menarcheal and post-menopausal women. For safety, special warnings are often placed on higher-risk groups, such as women over 35 who smoke, reflecting the focus of regulatory attention.

Q: What should be discussed with a healthcare provider before starting Melodene?

Official documents list specific criteria and risk factors that must be considered before initiating use. These include known absolute contraindications, like a history of blood clots, severe liver disease, and specific risk factors like smoking while over 35. These are the key topics that necessitate a discussion with a healthcare professional to determine eligibility.

Q: How long does it typically take to notice the described effects of Melodene?

The primary contraceptive effect begins after the body has reached a stable level of the hormones. Regulatory procedures for starting the medication often specify that the contraceptive effect is usually secured after the completion of seven consecutive days of active tablet use in the first cycle.

Q: Is it common for people to feel tired when starting Melodene?

Official adverse reaction lists for combined oral contraceptives indicate that feelings of unusual tiredness, weakness, or fatigue may be reported as a side effect. This is generally listed as a less common or non-specific finding in the comprehensive safety documentation.

Q: What is the difference between Melodene and its generic version?

Official regulatory bodies approve generic versions by requiring them to demonstrate bioequivalence to the brand-name product. This means the generic version must have the same active ingredients, strength, safety, quality, and intended use as Melodene. Essentially, they are required to function the same way in the body.

Q: Does alcohol consumption affect the safety or effectiveness of Melodene?

Some regulatory information or patient-facing documents explicitly advise caution, noting that alcohol may potentially affect the safety profile or the proper function of the drug.

Q: Why do some people need to stop taking Melodene suddenly?

Official safety documentation lists specific signs and symptoms that are listed as reasons for stopping the medication immediately and seeking medical care. Examples include the onset of jaundice (yellowing of the skin), first signs of blood clot formation (thrombosis), or the development of unusual, severe migraines or headaches.

Q: How quickly does Melodene leave the body after I stop taking it?

The elimination rate of the active ingredients is described by their biological half-life in the body. The half-life for the active hormones in Melodene, Ethinyl Estradiol and Gestodene, is typically documented to be in the range of 12 to 36 hours.

Q: Can taking Melodene make my skin more sensitive to the sun?

The official adverse reaction sections sometimes include a warning about a condition called chloasma, which is the development of patchy skin discoloration. Due to this possibility, regulatory information notes that women are often advised to avoid prolonged exposure to the sun or ultraviolet light while using the pill.

Q: Can Melodene affect sleep patterns or cause insomnia?

Adverse reaction lists for similar types of combined oral contraceptives frequently include difficulty in sleeping or insomnia as a possible side effect reported in trials.

Q: Is there a risk of withdrawal symptoms if Melodene is stopped?

Upon discontinuation of combined oral contraceptives, official labeling notes that a transient delay in ovulation may occur before the return to normal menstrual cycles. This means the body's natural cycle may take some time to re-establish itself.

Q: Does Melodene require any special monitoring or testing while in use?

Official documentation advises that regular follow-up visits are recommended while taking this medication. These visits may include routine checks such as blood pressure measurements and possibly blood or urine tests, which are used to monitor for any unwanted effects.

Q: Is Melodene used to treat any other conditions besides its main purpose?

While the primary purpose of Melodene is the prevention of pregnancy, some official documents for this combination, or similar Combined Oral Contraceptives, may state that it is also used for secondary non-contraceptive benefits. These can include the treatment of irregular menstrual cycles or helping with pre-menstrual symptoms.

Q: Can Melodene cause dry mouth or changes in appetite?

Adverse reaction sections for Combined Oral Contraceptives often list changes in appetite as a known side effect, though the frequency may be uncommon or less clearly defined. Dry mouth is generally not highlighted as a key adverse reaction in the official safety profile.

Q: Does Melodene interact with any common caffeinated beverages?

Some patient-facing regulatory information, or information for similar Combined Oral Contraceptives, notes that consuming it with caffeine may potentially reduce the absorption of the active ingredients.

Q: Is it possible for Melodene to cause a severe allergic reaction?

Official labeling indicates that known hypersensitivity to the active substances or to any of the other ingredients in the tablet is a contraindication. This means that a severe allergic reaction is a possibility addressed in the official risk profile.

Q: What are the key ingredients in Melodene besides the active drug?

Official labeling, such as DailyMed, provides a full description of the product's composition. This includes both the active ingredients—Ethinyl Estradiol and Gestodene—and the inactive ingredients, also known as excipients, which are used to form the tablet and coating.

How should Melodene be stored and disposed of?

How to Store and Dispose of Melodene?

The official storage and disposal requirements for Melodene are defined by regulatory bodies to maintain the stability of the active ingredients and ensure environmental safety.

Storage Conditions

Melodene tablets must be stored at a temperature that does not exceed 25 C.

Protection from light is mandatory; therefore, the medication should be kept in its original container or outer carton. As a universal requirement for prescription medicines, it must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Melodene should not be disposed of in household waste or flushed down the toilet (via wastewater). This restriction helps prevent synthetic hormones from entering the environment. Disposal must be carried out in accordance with local regulations, often through authorized pharmacy take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Melodene found in:

A-Z Index: